top of page
MOSTLY MICROBES AND INFECTIOUS DISEASES
Welcome to Mostly Microbes and Infectious Diseases. David Ojcius posts newspaper and journal articles in the broad field of microbiology.

Search


Modelling Fusobacterium lifestyles transitions by integrating transcriptomics and growth data
Highlights Reconstructed and curated of the genome-scale metabolic model (GEM) of Fusobacterium nucleatum Experimental data used to refine and validate the GEM, including biomass formulation with BOFdat (Biomass Objective Function from experimental data) Integrated transcriptomic data to build context-specific metabolic models Metabolic rewiring links F. nucleatum adaptation to colorectal cancer (CRC) context Provides a systems framework to explore host-microbe metabolic i
David Ojcius
34 minutes ago2 min read


A multi-glycoprotein synergized recombinant virus system resolves the research dilemma of Epstein-Barr virus entry and facilitates the development of entry-specific drugs or vaccines
Highlights A novel virus system rEBV-VSV was developed realizing efficient and native EBV entry via multi-synergetic glycoproteins with sensitive bioluminescence detection. rEBV-VSV was especially competent for rapid and high-throughput entry-inhibition evaluation of drugs, antibodies, or sera and accurate study of EBV entry mechanisms via flexible mutations or recombination on rEBV-VSV. Glycoprotein 42 (gp42) was found to mediate diverse functions of an important mutation L6
David Ojcius
1 day ago2 min read


Genomic atlas of Bifidobacterium infantis and B. longum informs infant probiotic design
Highlights Genome catalog of 4,098 B. infantis and B. longum shows distinct biogeography and ecology B. infantis is depleted in Westernized populations but highly common in LMIC infants Massively expanded B. infantis diversity and functions are absent from current probiotics Geo-specific strain library informs diet- and population-tailored infant probiotic design Summary Bifidobacterium longum and B. infantis are pioneer colonizers of the neonatal gut and are widely
David Ojcius
3 days ago1 min read


Can the shingles vaccine slow ageing? The evidence is surprisingly strong
D EMENTIA IS tragically common among the elderly. In 2021 57m people worldwide were thought to have the condition. Ageing is a risk factor for many other ailments too, ranging from chronic inflammation to a decline in organ function. A growing body of work, however, suggests that simply taking a course of the shingles vaccine can meaningfully slow the decline. The new data, from a range of countries, suggests that it cuts risk by 20%. Shingles is a painful skin condition cau
David Ojcius
6 days ago2 min read
Home: Blog2
Home: Subscribe

Home: Contact
bottom of page













